We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Genus plc (GNS) Ordinary 10p

Sell:4,864.00p Buy:4,870.00p 0 Change: 158.00p (3.16%)
FTSE 250:1.04%
Market closed Prices as at close on 30 November 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:4,864.00p
Buy:4,870.00p
Change: 158.00p (3.16%)
Market closed Prices as at close on 30 November 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:4,864.00p
Buy:4,870.00p
Change: 158.00p (3.16%)
Market closed Prices as at close on 30 November 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Genus PLC is a United Kingdom-based animal genetics company. The Company provides farmers with genetics that enable them to produce animal protein for breeding pigs and cattle, in the form of meat and milk. The Company’s operating segments includes Genus PIC, Genus ABS and Research and Development. The Genus PIC segment is engaged in porcine sales business. The Genus ABS segment is engaged in bovine sales business. The Company's development activities include developing and maintaining its porcine genetic nucleus herd and bovine pre-stud herds. The Company operates approximately around 25 countries on six continents, with research laboratories located in Madison, Wisconsin, United States.

Contact details

Address:
Matrix House, Basing View
BASINGSTOKE
RG21 4DZ
United Kingdom
Telephone:
+44 (01256) 347100
Website:
https://www.genusplc.com

Important dates

Future events
Final dividend payment date 10 December 2021 10/12/21
Past events
Trading Announcement 24 November 2021 24/11/21
AGM 24 November 2021 24/11/21
Final ex-dividend date 18 November 2021 18/11/21
Final results 09 September 2021 09/09/21
Interim dividend payment date 01 April 2021 01/04/21
Interim ex-dividend date 04 March 2021 04/03/21
Interim results 25 February 2021 25/02/21
Trading Announcement 18 January 2021 18/01/21
Final dividend payment date 11 December 2020 11/12/20

General stock information

EPIC:
GNS
ISIN:
GB0002074580
Market cap:
£3.18 billion
Shares in issue:
65.77 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE techMARK 100,FTSE 250,FTSE 350,FTSE All Share,FTSE techMARK All Share

Key personnel

  • Stephen Wilson
    Chief Executive, Executive Director
  • Alison Henriksen
    Chief Financial Officer, Executive Director
  • Elena Rice
    Chief Scientific Officer and Head of Research and Development
  • Dan Hartley
    Group General Counsel and Company Secretary
  • Angelle Rosata
    Group Human Resources Director
  • Bill Christianson
    Chief Operating Officer - Genus PIC
  • Jerry Thompson
    Chief Operating Officer - Genus ABS Beef
  • Nate Zwald
    Chief Operating Officer - Genus ABS Dairy

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.